Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
3,090,214
-
Share change
-
-102,699
-
Total reported value
-
$30,009,855
-
Price per share
-
$9.71
-
Number of holders
-
67
-
Value change
-
-$1,228,820
-
Number of buys
-
26
-
Number of sells
-
28
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q4 2024
As of 31 Dec 2024,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,090,214 shares.
The largest 10 holders included
One Capital Management, LLC, RAYMOND JAMES FINANCIAL INC, Portland Global Advisors LLC, FLOW TRADERS U.S. LLC, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/, Krilogy Financial LLC, IHT Wealth Management, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.